(Q41187544)

28 September 2017

title

Reduction in ERRα is associated with lichen sclerosus and vulvar squamous cell carcinoma (English)

1 reference

28 September 2017

1 reference

M Lagerstedt

1

1 reference

28 September 2017

R Huotari-Orava

2

1 reference

28 September 2017

R Nyberg

3

1 reference

28 September 2017

J U Mäenpää

4

1 reference

28 September 2017

E Snellman

5

1 reference

28 September 2017

S-L Laasanen

6

1 reference

28 September 2017

language of work or name

English

0 references

publication date

20 October 2015

1 reference

28 September 2017

1 reference

28 September 2017

volume

139

1 reference

28 September 2017

issue

3

1 reference

28 September 2017

page(s)

536-540

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

28 September 2017

1 reference

Childhood vulvar lichen sclerosus: an increasingly common problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Childhood lichen sclerosus--a challenge for clinicians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Review of squamous premalignant vulvar lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

The NR3B subgroup: an ovERRview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Estrogen Receptors as Therapeutic Targets in Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Transcriptional control of energy homeostasis by the estrogen-related receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

ERRs and cancers: effects on metabolism and on proliferation and migration capacities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Expression of oestrogen-related receptor alpha in human epidermis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Estrogen receptor (ER) and ER-related receptor expression in normal and atrophic human vagina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Estrogen receptor-related receptor-alpha (ERR-alpha) is dysregulated in inflammatory arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Loss of estrogen-related receptor α promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

The significance of the expression of ERRalpha as a potential biomarker in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Epigenetic and genetic dispositions of ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

The PGC-1/ERR signaling axis in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.10.016

10.1016/J.YGYNO.2015.10.016

7 January 2021

Identifiers

DOI

1 reference

28 September 2017

1 reference